Pharma and biotech R&D teams often grapple with weeks-long data analysis pipelines, a bottleneck Mithrl aims to eliminate with its AI-powered scientific decision engine. The company recently secured $20.0M in Series A funding to further its mission.
Mithrl's platform allows discovery researchers to build custom workflows and analyze complex datasets using natural language, cutting down analysis time from weeks to minutes. This automation frees scientists from manual coding, letting them focus on designing experiments and driving new discoveries. The Series A round saw participation from Obvious Ventures, Headline, and AGIHouse.
.png&w=3840&q=75)
.png&w=3840&q=75)